New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 13, 2012
10:12 EDTVRA, MCHP, GLF, BBEP, RDY, YUM, TSO, MTB, FRME, AVGO, ENOC, BGS, RFMD, HBC, DRC, CRL, LLYOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Avago (AVGO) upgraded to Buy from Neutral at Goldman... BreitBurn Energy (BBEP) upgraded to Neutral from Underperform at Credit Suisse... Charles River Labs (CRL) upgraded to Outperform from Market Perform at Wells Fargo... Dresser-Rand (DRC) upgraded to Positive from Neutral at Susquehanna... First Merchants (FRME) upgraded to Outperform from Market Perform at Keefe Bruyette... GulfMark Offshore (GLF) upgraded to Outperform from Market Perform at Wells Fargo... HSBC (HBC) upgraded to Buy from Hold at Deutsche Bank... M&T Bank (MTB) upgraded to Outperform from Market Perform at Keefe Bruyette... Microchip (MCHP) upgraded to Neutral from Sell at Goldman... RF Micro Devices (RFMD) upgraded to Overweight from Equal Weight at Barclays... Tesoro (TSO) upgraded to Outperform from Neutral at Credit Suisse... Vera Bradley (VRA) upgraded to Buy from Hold at Jefferies... B&G Foods (BGS) upgraded to Outperform from Sector Perform at RBC Capital... Yum! Brands (YUM) upgraded to Buy from Neutral at Goldman... Charles River Labs (CRL) upgraded to Overweight from Neutral at JPMorgan... Eli Lilly (LLY) upgraded to Neutral from Underperform at Cowen... EnerNOC (ENOC) upgraded to Outperform from Market Perform at Raymond James... Dr. Reddy's Labs (RDY) upgraded to Outperform from Neutral at Credit Suisse.
News For AVGO;BBEP;DRC;FRME;GLF;HBC;MTB;MCHP;RFMD;TSO;VRA;BGS;YUM;LLY;ENOC;RDY;CRL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
April 20, 2015
08:08 EDTLLYEli Lilly announces positive results from ixekizumab study
Eli Lilly and Company announced that the investigational medicine ixekizumab was statistically superior to placebo in the treatment of patients with active psoriatic arthritis, or PsA, as demonstrated by the proportion of patients achieving an ACR 20 response. ACR 20 is a standard assessment that represents a 20% reduction in disease signs and symptoms as defined by the American College of Rheumatology response criteria. During the 24-week, Phase 3 study, titled SPIRIT-P1, patients who were na´ve to biologic disease-modifying antirheumatic drugs were treated with one of two different ixekizumab dosing regimens or placebo.
07:58 EDTMTBM&T Bank reports Q1 non-GAAP EPS $1.68, consensus $1.76
Subscribe for More Information
07:20 EDTLLYAmerican Association for Cancer Research to hold annual meeting
Subscribe for More Information
06:19 EDTTSOCiti still bullish on U.S. Refiners, Marathon Petroleum a top pick
Subscribe for More Information
April 17, 2015
08:04 EDTMTBHudson City Bancorp and M&T Bank announce extension to complete merger
Subscribe for More Information
April 16, 2015
12:16 EDTLLYEli Lilly and Bristol-Myers restructure Erbitux collaboration in N. America
Subscribe for More Information
April 15, 2015
13:06 EDTMTBHudson City Bancorp probed over minority loans, Bloomberg says
Subscribe for More Information
12:51 EDTMTBHudson City Bancorp probed over minority loans, Bloomberg says
Subscribe for More Information
10:19 EDTDRCOptions with decreasing implied volatility
Subscribe for More Information
10:00 EDTYUMOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:41 EDTLLYEBD Group to hold a forum
ChinaBio Partnering Forum 2015 is being held in Shanghai, China on April 15-16.
06:09 EDTYUMYum! Brands implied volatility of 30 at upper end of index
06:04 EDTYUMYum! Brands initiated with a Market Perform at Cowen
Target $81.
April 14, 2015
17:00 EDTVRAVera Bradley says Chief Marketing Officer Angel Ilagan to leave
Angel Ilagan, Chief Marketing Officer of Vera Bradley, will be leaving the company effective April 17. The company has begun a search for a new Chief Marketing Officer. In the interim, Stephanie Scheele, Vice President of Marketing, will oversee the marketing area.
10:34 EDTDRCOptions with decreasing implied volatility
Subscribe for More Information
08:14 EDTMCHPBMW implements Microchip's INICs in 2 Series Active Tourer
Subscribe for More Information
April 13, 2015
14:29 EDTYUMYum! Brands volatility increases into Q1 and outlook
Yum! Brands April call option implied volatility is at 37, April weekly is at 41, May is at 28; compared to its 26-week average of 22 according to Track Data, suggesting large price movement into the expected release of Q1 results on April 22.
10:00 EDTMTBOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:02 EDTYUMYum! Brands implied volatility of 29 at upper end of index
05:42 EDTMTBM&T Bank downgraded to Underperform from Market Perform at Wells Fargo
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use